ProfileGDS4718 / 205969_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 39% 37% 30% 40% 39% 30% 37% 37% 32% 37% 39% 33% 28% 33% 61% 35% 32% 43% 30% 29% 40% 41% 40% 33% 40% 42% 35% 32% 28% 33% 53% 44% 35% 38% 36% 36% 33% 36% 44% 24% 45% 42% 62% 64% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9595139
GSM549102patient 115, normal, homogenized [OPG study]4.8703937
GSM549104patient 119, normal, homogenized [OPG study]4.5052930
GSM549108patient 138, normal, homogenized [OPG study]5.0520540
GSM549119patient 077, normal, homogenized [OPG study]4.9530939
GSM549133patient 032, cancer, homogenized [OPG study]4.4861930
GSM549139patient 042, cancer, homogenized [OPG study]4.8523837
GSM549099patient 107, normal, homogenized [OPG study]4.8865237
GSM549109patient 139, normal, homogenized [OPG study]4.6587132
GSM549110patient 046, normal, homogenized [OPG study]4.846637
GSM549114patient 063, normal, homogenized [OPG study]4.9184839
GSM549122patient 082, normal, homogenized [OPG study]4.6635533
GSM549134patient 033, cancer, homogenized [OPG study]4.4467828
GSM549136patient 036, cancer, homogenized [OPG study]4.6229233
GSM549140patient 044, cancer, homogenized [OPG study]6.1675761
GSM549111patient 047, normal, homogenized [OPG study]4.734235
GSM549113patient 057, normal, homogenized [OPG study]4.571532
GSM549132patient 031, cancer, homogenized [OPG study]5.1466743
GSM549137patient 038, cancer, homogenized [OPG study]4.5195430
GSM549142patient 047, cancer, homogenized [OPG study]4.6057829
GSM549100patient 110, normal, homogenized [OPG study]5.0056940
GSM549107patient 135, normal, homogenized [OPG study]5.0173941
GSM549115patient 068, normal, homogenized [OPG study]4.9179840
GSM549116patient 072, normal, homogenized [OPG study]4.6318533
GSM549120patient 078, normal, homogenized [OPG study]4.9643940
GSM549131patient 030, cancer, homogenized [OPG study]5.0318242
GSM549118patient 074, normal, homogenized [OPG study]4.7475735
GSM549129patient 027, cancer, homogenized [OPG study]4.6503232
GSM549123patient 088, normal, homogenized [OPG study]4.4557428
GSM549124patient 006, cancer, homogenized [OPG study]4.7234233
GSM549126patient 015, cancer, homogenized [OPG study]5.6924853
GSM549128patient 025, cancer, homogenized [OPG study]5.1723544
GSM549103patient 117, normal, homogenized [OPG study]4.8348435
GSM549117patient 073, normal, homogenized [OPG study]4.8646638
GSM549138patient 041, cancer, homogenized [OPG study]4.7678436
GSM549141patient 045, cancer, homogenized [OPG study]4.7173236
GSM549130patient 028, cancer, homogenized [OPG study]4.6933
GSM549101patient 111, normal, homogenized [OPG study]4.847336
GSM549105patient 128, normal, homogenized [OPG study]5.2016944
GSM549106patient 134, normal, homogenized [OPG study]4.244724
GSM549112patient 048, normal, homogenized [OPG study]5.2122745
GSM549125patient 011, cancer, homogenized [OPG study]5.1058242
GSM549127patient 024, cancer, homogenized [OPG study]6.3044562
GSM549135patient 035, cancer, homogenized [OPG study]6.3893464